The mission of the TRAC is to pool the expertise and resources of an outstanding team of senior tuberculosis (TB) investigators at the three institutions in order to expand the number of investigators in the field of TB research and to promote innovative multidisciplinary TB research.
Weill Cornell Medicine’s Center for Global Health, GHESKIO (Haiti), the Mérieux Foundation, the Pan American Health Organization (PAHO), and New York University co-hosted an event on September 22nd coinciding with the UN General Assembly, focused on the intersection of infectious and non-communicable diseases. Dr. Jarbas Barbosa, Director of PAHO, delivered the keynote address, and emphasized the urgent need for integrated health strategies to address both infectious agents and chronic conditions that increasingly affect the same populations.
We are proud to share that Dr. Carl F. Nathan, R.A. Rees Pritchett Professor of Microbiology at Weill Cornell Medicine, has been awarded the David and Beatrix Hamburg Award for Advances in Biomedical Research and Clinical Medicine by the National Academy of Medicine.
We are proud to share that Dr. Jyoti Mathad, a faculty member at our NYC-TRAC, has played a leading role in a new global initiative by the World Health Organization (WHO) to address inequities in tuberculosis (TB) research for pregnant and lactating women. Over the past two years, Dr. Mathad has co-led the Therapeutics Working Group of the WHO consensus team, helping to develop critical recommendations that place pregnant and lactating women at the forefront of TB therapeutics research.
Our center is now accepting applications for the NYC-TRAC Developmental Award. This program supports early-stage and established investigators with high-impact ideas aimed at advancing tuberculosis research, prevention, and treatment.
Letter of Intent (required) August 15, 2025
Full Application (by invitation) September, 2025
Purpose: Seed funding for innovative TB research projects that can evolve into full-scale grants or clinical studies.
